We read with great interest the recent article by Wu et al, titled “KCTD9 Expression Predicts Immunotherapy Response and Enhances Anti-PD-1 Efficacy in Colon Adenocarcinoma[1]”. Here, KCTD9 is linked to colon adenocarcinoma.